Author | Howard A. "Skip" Burris, III, MD, FASCO, FACP | OncLive

Author | Howard A. "Skip" Burris, III, MD, FASCO, FACP

Articles

Dr. Burris on Investigational Approaches in TNBC

February 05, 2020

Video

Howard A. "Skip" Burris, III, MD, FASCO, FACP, chief medical officer and president, Clinical Operations, Sarah Cannon Research Institute, 2019-2020 ASCO president-elect, and a 2014 Giant of Cancer Care® in Drug Development, discusses investigational immunotherapy approaches in triple-negative breast cancer (TNBC).

Dr. Burris on Ongoing Research With ADCs in TNBC

January 18, 2020

Video

Howard A. "Skip" Burris, III, MD, FASCO, FACP, chief medical officer and president, Clinical Operations, Sarah Cannon Research Institute, 2019 ASCO president-elect, and a 2014 Giant of Cancer Care® in Drug Development, discusses ongoing research with antibody-drug conjugates (ADCs) in triple-negative breast cancer.

x